SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025

Core Insights - Zealand Pharma is hosting a Capital Markets Day in London on December 11, 2025, focusing on obesity and related therapies [1][4] - The company aims to position itself as a key player in the evolving market for weight loss therapies, supported by a differentiated pipeline and strong partnerships [2][5] - Zealand Pharma is entering a significant phase with upcoming Phase 2 and Phase 3 data presentations for its drug candidates, petrelintide and survodutide, respectively [3] Company Overview - Zealand Pharma A/S is a biotechnology company specializing in peptide-based medicines, with over 10 drug candidates in clinical development, including two that have reached the market [5][6] - The company has established development and commercial partnerships with various pharmaceutical companies [5] Event Details - The Capital Markets Day will feature presentations from management and external experts in the obesity field, including notable researchers [3] - Further logistical details for investors and analysts will be provided in the coming weeks, with a live webcast available for those unable to attend in person [4]